Evoke Pharma Inc. (EVOK)

[Stratton Oakmont]

Not a scam, but yes think we will see lower. A proven drug that worked in a Phase 2 study in a different delivery method unexpectedly failed a Phase 3 study although the results were mixed and need further analysis to draw definitive conclusions. As this is company's only drug, definitely a gamble, could pay off big time if it ends up working, but if it doesn't will end in bankruptcy. Think we will see lower before any potential upside.